SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Solid Biosciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$5.92+0.39 (+7.05%)
Close on Oct 19, 2026
- Market cap
- $850.64M
- P/E (TTM)
- –
- Dividend yield
- –
Solid Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Market Cap | $634.77M | $166.30M |
| Enterprise Value | $257.07M | $88.19M |
| PB Ratio | 1.70 | 2.03 |
| P/TBV Ratio | 1.70 | 2.29 |
Income (trailing twelve months)
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Operating Income | -$179.21M | -$21.40M |
| Pretax Income | -$174.20M | -$14.34M |
| EBITDA | -$177.57M | -$16.91M |
| EPS (Diluted) | -$1.99 | -$0.83 |
Returns
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -45.7% | -38.1% |
Balance sheet
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $377.70M | $61.43M |
| Net Cash (Debt) | $377.70M | $15.35M |
| Net Cash Per Share | $3.52 | $0.66 |
| Equity (Book Value) | $374.08M | $49.09M |
| Book Value Per Share | $3.49 | $1.37 |
| Tangible Book Value | $374.08M | $23.52M |
| Working Capital | $366.52M | $76.81M |
Financial position
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Current Ratio | 13.82 | 3.34 |
| Quick Ratio | 13.21 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$156.29M | -$12.35M |
| Capital Expenditures | -$1.15M | -$1.08M |
| Free Cash Flow | -$157.44M | -$20.22M |
| FCF Per Share | -$1.47 | -$0.42 |
Efficiency
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Employee Count | 121 | 74 |
Dividends and yields
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| FCF Yield | -24.8% | -8.72% |
Shares
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 107,225,000 | 58,127,000 |
| Shares Change (YoY) | 114.4% | 10.9% |
| Shares Change (QoQ) | 6.84% | 0.54% |
| Float | 78,569,800 | 49,136,700 |
| Shares Held by Insiders | 26.7% | 11.6% |
| Shares Held by Institutions | 106.8% | 59.4% |
Taxes
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Solid Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | 4.27 | -0.22 |
Calculated by StockData from Solid Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.